Glycoproteinosis

Watchlist
Retrieved
2021-01-18
Source
Trials
Drugs

Glycoproteinosis are lysosomal storage diseases affecting glycoproteins, resulting from defects in lysosomal function. The term is sometimes reserved for conditions involving degradation of glycoproteins.

Types

  • (E77.0) Defects in post-translational modification of lysosomal enzymes
    • Mucolipidosis II (I-cell disease)
    • Mucolipidosis III (pseudo-Hurler polydystrophy)
  • (E77.1) Defects in glycoprotein degradation
    • Aspartylglucosaminuria
    • Fucosidosis
    • Mannosidosis
    • Sialidosis (mucolipidosis I)

Another type, recently characterized, is galactosialidosis.